戻る
「早戻しボタン」を押すと検索画面に戻ります。

今後説明を表示しない

[OK]

コーパス検索結果 (1語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します
1 s were compared by sex, race, histology, and hereditary cancer syndrome.
2 half of the alleles associated with a common hereditary cancer syndrome.
3               von Hippel-Lindau disease is a hereditary cancer syndrome.
4 olorectal, gastric, or pancreatic cancer for hereditary cancer syndromes.
5  unusual in an individual patient, except in hereditary cancer syndromes.
6 advised for patients and family members with hereditary cancer syndromes.
7 roduction by members of families affected by hereditary cancer syndromes.
8 ts with germline mutations associated with a hereditary cancer syndrome (51%) reported a CRC diagnosi
9 mmended, genetic testing of minors for adult hereditary cancer syndromes, along with risks and benefi
10 quencing, 79 had mutations associated with a hereditary cancer syndrome and 21 had variants of uncert
11 tumor suppressor gene (VHL) underlie the VHL hereditary cancer syndrome and also occur in most sporad
12 checkpoint control have been seen in certain hereditary cancer syndromes and at early stages of cell
13 he clinical profile, including the extent of hereditary cancer syndromes and family history of cancer
14 suppressor gene causes the von Hippel-Lindau hereditary cancer syndrome, and somatic mutations of thi
15                                       Though hereditary cancer syndromes are rare, their study has pr
16 way deregulation in human cancer and certain hereditary cancer syndromes, as well as in murine models
17                          Lynch syndrome is a hereditary cancer syndrome associated with high risks of
18 onal symposium on the surgical management of hereditary cancer syndromes at the annual ASCO and SSO m
19 ed with increased susceptibility not only to hereditary cancer syndromes but also to other diseases;
20         von Hippel-Lindau (VHL) disease is a hereditary cancer syndrome caused by germ line mutation
21         von Hippel-Lindau (VHL) disease is a hereditary cancer syndrome caused by germline mutations
22 ngs thus link cytokinetic abnormalities to a hereditary cancer syndrome characterized by chromosomal
23 crine neoplasia (MEN) types 1 and 2 are rare hereditary cancer syndromes expressing a variety of main
24                               There are also hereditary cancer syndromes for which testing is not yet
25 These results indicate that, as with certain hereditary cancer syndromes, genomic destabilization is
26     Great interest in predictive testing for hereditary cancer syndromes has been reported.
27                       More than 20 different hereditary cancer syndromes have now been defined and at
28                                Screening for hereditary cancer syndromes in patients with CRC should
29 ablished guidelines recommend evaluation for hereditary cancer syndromes in patients younger than 50
30 with evaluable data, 35% had an identifiable hereditary cancer syndrome, including 23 with Lynch synd
31 ion genetic testing is now possible for many hereditary cancer syndromes, including hereditary nonpol
32                                              Hereditary cancer syndromes infer high cancer risks and
33                                    This rare hereditary cancer syndrome is characterized by bone infa
34   It has been suggested that MEN1, like many hereditary cancer syndromes, is caused by mutation in a
35 cycle enzyme fumarate hydratase (FH) cause a hereditary cancer syndrome known as hereditary leiomyoma
36 cal, pathologic, and genetic features of the hereditary cancer syndromes known to be associated with
37 le genes have been implicated in single-gene hereditary cancer syndromes, many of which are associate
38 In this review, we highlight the most common hereditary cancer syndromes, most attributable to genes
39 all percent of colorectal cancers are due to hereditary cancer syndromes, of which hereditary nonpoly
40                                              Hereditary cancer syndromes provide powerful insights in
41 DNA testing is no small matter, given that a hereditary cancer syndrome's sequelae may be far reachin
42                         The possibility of a hereditary cancer syndrome should be assessed for every
43          Recent studies of a relatively rare hereditary cancer syndrome, von Hippel-Lindau (VHL) dise
44                  Patients with an identified hereditary cancer syndrome were compared with those with
45  age 40 years or younger and lacking a known hereditary cancer syndrome were identified from the CCFR
46 e-ubiquitinating enzyme BAP1 is mutated in a hereditary cancer syndrome with increased risk of mesoth
47 now have a good opportunity to better define hereditary cancer syndromes with associated hematologic
48 e introduction of genomic technologies, more hereditary cancer syndromes with hematologic malignancie

WebLSDに未収録の専門用語(用法)は "新規対訳" から投稿できます。